Therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia

BACKGROUND: Cambodia stopped using co-blistered, non-fixed, artesunate-mefloquine (ASMQ) in 2008 when treatment failure rates approximated 20%. Fixed dose combination (FDC) ASMQ is efficacious against acute uncomplicated, drug resistant Plasmodium falciparum malaria in Southeast Asia but has not bee...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Leang, Rithea, Ros, Sakun, Duong, Socheat, Navaratnam, Visweswaran, Lim, Pharath, Ariey, Frédéric, Kiechel, Jean-René, Ménard, Didier, Taylor, Walter RJ
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3852322/
https://ncbi.nlm.nih.gov/pubmed/24060207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-12-343
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars